Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 161 Neoplasm Metastasis 22 Neoplasms 20 Advanced Breast Cancer 13 Ovarian Neoplasms 11 Carcinoma, Non-Small-Cell Lung 10 Hereditary Sensory and Autonomic Neuropathies 9 Endometrial Neoplasms 8 Triple Negative Breast Neoplasms 7 Colorectal Neoplasms 6 Uterine Cervical Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Prostatic Neoplasms 5 Recurrence 4 Neoplasms by Site 4 Multiple Endocrine Neoplasia Type 1 4 Breast Diseases 4 Small Cell Lung Carcinoma 3 Head and Neck Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Uterine Neoplasms 2 Stomach Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Locally Advanced (Inoperable) or Metastatic Breast Cancer 2 Liposarcoma 2 HER2-positive Metastatic Breast Cancer 2 Advanced Solid Tumors 2 Advanced Solid Tumor 2 Urologic Neoplasms 1

Interventions

pembrolizumab 6 Proton Therapy 3 spartalizumab 2 Rosuvastatin Calcium 2 Paclitaxel 2 Immune Checkpoint Inhibitors 2 Cetuximab 2 toripalimab 1 sotorasib 1 peposertib 1 osimertinib 1 necitumumab 1 mirdametinib 1 leronlimab 1 apatinib 1 amivantamab 1 abemaciclib 1 Valganciclovir 1 Trastuzumab 1 Therapeutics 1 Rifampin 1 Radiotherapy 1 PankoMab-GEX 1 Panitumumab 1 Midazolam 1 Metformin 1 MEK inhibitor I 1 Jupiter 1 JPT1 protein, human 1 Itraconazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Solid Tumor, Adult × Fulvestrant × Clear all

NCT04092673 2024-05-21

Zotatifin

Effector Therapeutics

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡